Journal of Medical Cases, ISSN 1923-4155 print, 1923-4163 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Med Cases and Elmer Press Inc
Journal website https://jmc.elmerpub.com

Case Report

Volume 16, Number 1, January 2025, pages 23-27


Pulmonary Mucormycosis in an Older Acute Myeloid Leukemia Patient

Figures

Figure 1.
Figure 1. Chest CT changes during the course of pneumonia. (a) Large areas of consolidation (white arrow) in the middle-lower right lobe and pleural effusion during the first hospitalization when the patient was infected with Mycoplasma pneumoniae. (b) On the second admission, the consolidation (white arrow) in the right middle-lower lobe was significantly absorbed and decreased, and the pleural effusion disappeared. (c) After 2 weeks of nonspecific antifungal treatment, the consolidation (white arrow) in the right lobe progressed, accompanied by obstructive inflammation and lymphangitis. Pleural effusion also appeared. (d) Video bronchoscopy image showing a black fungating mass in the right principal bronchus (white arrow). (e) No further progression in the right lobe (white arrow) after 26 days of anti-mucor therapy. CT: computed tomography.
Figure 2.
Figure 2. The clinical and treatment course of the patient. The first day of chemotherapy is considered as day 1 (d1). ANC: absolute neutrophil count; PCT: procalcitonin; AZA: azacytidine; Pcz: posaconazole; ABCD: amphotericin B cholesteryl sulfate complex for injection.